Slideshow

Efficacy Vs Tolerability in Bipolar Depression

Author(s):

James Phelps, MD

Which is more important, for whom?

Related Videos
World Bipolar Day
bipolar
bipolar
bipolar
journey
Related Content
bipolar depression
April 15th 2025

Investigating the SAINT iTBS Protocol for Bipolar I Depression

Kenneth J. Bender, PharmD, MA
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
FDA
April 1st 2025

New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia

Leah Kuntz
Four Myths About Lamotrigine
August 3rd 2021

Four Myths About Lamotrigine

Chris Aiken, MD Kellie Newsome, PMH-NP
bipolar
March 4th 2025

BHV-7000 for Bipolar Disorder Fails in Phase 2/3 Trial

Leah Kuntz
Andril Ylanskyl/AdobeStock
February 26th 2025

Agree to Disagree: A Collaborative Perspective From a Treatment Team and Disagreeing Patient

Fayzan Rab Jed Peter Mangal, MD
© 2025 MJH Life Sciences

All rights reserved.